::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

MANAGEMENT FOR PROSTATE CANCER TREATMENT RELATED POSTERIOR URETHRAL AND BLADDER NECK STENOSIS WITH STENTS.

AUTHORS:

Dr Nazrah Shabbir ,Dr Farkhanda Naseem,Dr Feroz Tariq.

ABSTRACT:

Approximately 200k men have been diagnosing with prostate cancer annually in the US. Those getting treatment of prostate cancer are at definite risk of having posterior urethral stricture. Radical prostatectomy has complication in 1 to 25% of the cases whereas radiation therapy may end up with forming stricture by the side of complete length of posterior urethra. Luckily many of the strictures are manageable to simple endoscopic technique. Commonly two methods could be used in men. In the first method basically there is abdominal or open perineal surgery in which the strictured section is cut out and a conjunction is established. After successful removing the stricture through this surgery the consequences may end up having incontinence and other technically challenging. And the other option which is known as urinary diversion the last expedient left for final solution. A study conducted in 2001 has stated that Urolume urethral stent used for unmanageable stricture related treatment for prostate cancer. Initial reports collected were in favor of an overall success with more than 80%. Participants who were having Urolme stents placed because of posterior urethral stricture as a result of prostate cancer included in the study. Total 40 men were included in the study. The current study has reported that Urolume stenting is appreciated for them who are suffering from post-prostate cancer treatment stricture and for those who are not in favor of going under open reconstructive surgery.